Fibrogen Stock Price on June 25, 2021

FGEN Stock  USD 1.07  0.07  6.14%   
Below is the normalized historical share price chart for FibroGen extending back to November 14, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of FibroGen stands at 1.07, as last reported on the 24th of April, with the highest price reaching 1.26 and the lowest price hitting 1.05 during the day.
IPO Date
14th of November 2014
200 Day MA
1.287
50 Day MA
1.9148
Beta
0.736
 
Yuan Drop
 
Covid
If you're considering investing in FibroGen Stock, it is important to understand the factors that can impact its price. FibroGen appears to be out of control, given 3 months investment horizon. FibroGen secures Sharpe Ratio (or Efficiency) of 0.0551, which denotes the company had a 0.0551% return per unit of standard deviation over the last 3 months. By reviewing FibroGen's technical indicators, you can evaluate if the expected return of 0.77% is justified by implied risk. Please utilize FibroGen's Semi Deviation of 9.27, downside deviation of 10.73, and Mean Deviation of 8.22 to check if our risk estimates are consistent with your expectations.
  
At this time, FibroGen's Liabilities And Stockholders Equity is very stable compared to the past year. As of the 24th of April 2024, Capital Stock is likely to grow to about 1 M, though Total Stockholder Equity is likely to grow to (194 M). . As of the 24th of April 2024, Price To Sales Ratio is likely to drop to 0.55. In addition to that, Price Earnings Ratio is likely to drop to -0.32. FibroGen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0551

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsFGEN
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 14.04
  actual daily
96
96% of assets are less volatile

Expected Return

 0.77
  actual daily
15
85% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
4
96% of assets perform better
Based on monthly moving average FibroGen is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of FibroGen by adding it to a well-diversified portfolio.
Price Book
53.8258
Enterprise Value Ebitda
(0.17)
Price Sales
0.869
Shares Float
83 M
Wall Street Target Price
1.75

FibroGen Valuation on June 25, 2021

It is possible to determine the worth of FibroGen on a given historical date. On June 25, 2021 FibroGen was worth 12.7 at the beginning of the trading date compared to the closed value of 12.58. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of FibroGen stock. Still, in general, we apply an absolute valuation method to find FibroGen's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of FibroGen where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against FibroGen's related companies.
 Open High Low Close Volume
04/07/2022
  12.70    12.80    12.27    12.58    419,500  
  12.55    12.67    12.28    12.43    458,300  
Backtest FibroGen  |  FibroGen History  |  FibroGen Valuation Next  
Open Value
12.7
12.58
Closing Value
54.83
Upside

FibroGen Trading Date Momentum on June 25, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

FibroGen Fundamentals Correlations and Trends

By evaluating FibroGen's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among FibroGen's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. FibroGen financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About FibroGen Stock history

FibroGen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for FibroGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in FibroGen will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing FibroGen stock prices may prove useful in developing a viable investing in FibroGen
Last ReportedProjected for Next Year
Common Stock Shares Outstanding97.3 M78.2 M
Net Loss-264.3 M-251.1 M

FibroGen Quarterly Net Working Capital

113.89 Million

FibroGen Stock Technical Analysis

FibroGen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of FibroGen technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of FibroGen trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

FibroGen Period Price Range

Low
April 7, 2022
-0.12  -0.94%
High

 12.70 

     

 12.58 

FibroGen April 24, 2024 Market Strength

Market strength indicators help investors to evaluate how FibroGen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading FibroGen shares will generate the highest return on investment. By undertsting and applying FibroGen stock market strength indicators, traders can identify FibroGen entry and exit signals to maximize returns

FibroGen Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for FibroGen's price direction in advance. Along with the technical and fundamental analysis of FibroGen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of FibroGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether FibroGen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of FibroGen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fibrogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fibrogen Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.
Note that the FibroGen information on this page should be used as a complementary analysis to other FibroGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for FibroGen Stock analysis

When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stocks Directory
Find actively traded stocks across global markets
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is FibroGen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.536
Earnings Share
(2.92)
Revenue Per Share
1.518
Quarterly Revenue Growth
(0.21)
Return On Assets
(0.36)
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.